drugset / Trial / NCT06383013
BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic lower leg and foot ulcer.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2027-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BB-101 | Unknown | — | Topical |